1. Home
  2. Pharma & Healthcare
  3. Global and United States Gastrointestinal Therapeutics and Diagnostics Market 2020 by Company, Type and Application, Forecast to 2025

Global and United States Gastrointestinal Therapeutics and Diagnostics Market 2020 by Company, Type and Application, Forecast to 2025

Publication Month: Mar 2020 | No. of Pages: 91 Published By: Global Info Research
Single User License: US $ 3980
Corporate User License: US $ 7960

Market Overview
The global Gastrointestinal Therapeutics and Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 54850 million by 2025, from USD 50010 million in 2019.

The Gastrointestinal Therapeutics and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Gastrointestinal Therapeutics and Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Gastrointestinal Therapeutics and Diagnostics market has been segmented into Diagnostics, Therapeutics, etc.

Breakdown by Application, Gastrointestinal Therapeutics and Diagnostics has been segmented into Gastroenteritis, GI Bleeding, Irritable Bowel Syndrome, Peptic Ulcer Disease (PUD), Others, etc.

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastrointestinal Therapeutics and Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastrointestinal Therapeutics and Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastrointestinal Therapeutics and Diagnostics market.

For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Gastrointestinal Therapeutics and Diagnostics Market Share Analysis
Gastrointestinal Therapeutics and Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Gastrointestinal Therapeutics and Diagnostics revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastrointestinal Therapeutics and Diagnostics revenue and market share for each player covered in this report.

The major players covered in Gastrointestinal Therapeutics and Diagnostics are: Abbott Laboratories, Johnson & Johnson, AstraZeneca, Eisai, Takeda Pharmaceutical Company, Salix Pharmaceuticals, etc. Among other players domestic and global, Gastrointestinal Therapeutics and Diagnostics market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers
Abbott Laboratories
Johnson & Johnson
AstraZeneca
Eisai
Takeda Pharmaceutical Company
Salix Pharmaceuticals

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:
Diagnostics
Therapeutics

Market segment by Application, can be divided into
Gastroenteritis
GI Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (PUD)
Others

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Gastrointestinal Therapeutics and Diagnostics
1.2 Classification of Gastrointestinal Therapeutics and Diagnostics by Type
1.2.1 Overview: Global Gastrointestinal Therapeutics and Diagnostics Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type in 2019
1.2.3 Diagnostics
1.2.4 Therapeutics
1.3 Global Gastrointestinal Therapeutics and Diagnostics Market by Application
1.3.1 Overview: Global Gastrointestinal Therapeutics and Diagnostics Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Gastroenteritis
1.3.3 GI Bleeding
1.3.4 Irritable Bowel Syndrome
1.3.5 Peptic Ulcer Disease (PUD)
1.3.6 Others
1.4 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
1.5 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Regions (2015-2020)
1.7 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2015-2025)
1.7.2 Europe Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2015-2025)
1.7.3 Asia Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2015-2025)
1.7.4 South America Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2015-2025)

2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eisai
2.4.1 Eisai Details
2.4.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eisai SWOT Analysis
2.4.4 Eisai Product and Services
2.4.5 Eisai Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Takeda Pharmaceutical Company
2.5.1 Takeda Pharmaceutical Company Details
2.5.2 Takeda Pharmaceutical Company Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Takeda Pharmaceutical Company SWOT Analysis
2.5.4 Takeda Pharmaceutical Company Product and Services
2.5.5 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Salix Pharmaceuticals
2.6.1 Salix Pharmaceuticals Details
2.6.2 Salix Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Salix Pharmaceuticals SWOT Analysis
2.6.4 Salix Pharmaceuticals Product and Services
2.6.5 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players
3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Players (2015-2020)
3.2 United States Gastrointestinal Therapeutics and Diagnostics Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Gastrointestinal Therapeutics and Diagnostics Players Market Share
3.3.2 Top 10 Gastrointestinal Therapeutics and Diagnostics Players Market Share

4 North America Market Size and Forecast by Countries
4.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Countries (2015-2020)
4.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Countries (2015-2026)
4.3 United States Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
4.4 Canada Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
4.5 Mexico Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries
5.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Countries (2015-2020)
5.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Countries (2015-2026)
5.3 Germany Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
5.4 France Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
5.5 UK Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
5.6 Russia Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
5.7 Italy Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Regions (2015-2020)
6.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Regions (2015-2026)
6.3 China Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
6.4 Japan Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
6.5 Korea Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
6.6 India Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
6.7 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries
7.1 South America Gastrointestinal Therapeutics and Diagnostics Market Size by Countries (2015-2020)
7.2 South America Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
7.4 Argentina Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Regions (2015-2020)
8.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
8.4 UAE Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
8.5 Egypt Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)
8.6 South Africa Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2015-2025)

9 Market Size Segment by Type
9.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Type (2015-2025)
9.1.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
9.1.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Type (2020-2025)
9.2 United States Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Type (2015-2025)
9.2.1 United States Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
9.2.2 United States Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application
10.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Application (2015-2025)
10.1.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)
10.1.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Application (2020-2025)
10.2 United States Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Application (2015-2025)
10.2.1 United States Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)
10.2.2 United States Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US

Tables and Figures

List of Tables

Table 1. Global Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Gastrointestinal Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Regions (2015-2020)
Table 7. Global Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Regions (2020-2025)
Table 9. Abbott Laboratories Corporate Information, Location and Competitors
Table 10. Abbott Laboratories Major Business
Table 11. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 12. Abbott Laboratories SWOT Analysis
Table 13. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 14. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Johnson & Johnson Corporate Information, Location and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Total Revenue (USD Million) (2018-2019)
Table 18. Johnson & Johnson SWOT Analysis
Table 19. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 20. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. AstraZeneca Corporate Information, Location and Competitors
Table 22. AstraZeneca Major Business
Table 23. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 24. AstraZeneca SWOT Analysis
Table 25. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 26. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Eisai Corporate Information, Location and Competitors
Table 28. Eisai Major Business
Table 29. Eisai Gastrointestinal Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 30. Eisai SWOT Analysis
Table 31. Eisai Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 32. Eisai Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Takeda Pharmaceutical Company Corporate Information, Location and Competitors
Table 34. Takeda Pharmaceutical Company Major Business
Table 35. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 36. Takeda Pharmaceutical Company SWOT Analysis
Table 37. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 38. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Salix Pharmaceuticals Corporate Information, Location and Competitors
Table 40. Salix Pharmaceuticals Major Business
Table 41. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 42. Salix Pharmaceuticals SWOT Analysis
Table 43. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 44. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Global Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Players (2015-2020)
Table 46. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Players (2015-2020)
Table 47. Key Players Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) in United States (2015-2020)
Table 48. Key Players Gastrointestinal Therapeutics and Diagnostics Revenue Share in United States (2015-2020)
Table 49. North America Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 50. North America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 51. North America Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 52. North America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2020-2026)
Table 53. Europe Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 54. Europe Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 55. Europe Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 56. Europe Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2020-2026)
Table 57. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 58. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 59. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 60. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2020-2026)
Table 61. South America Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 62. South America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 63. South America Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 64. South America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2020-2026)
Table 65. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 66. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 67. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 68. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2020-2026)
Table 69. Global Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Type (2015-2020)
Table 70. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Type (2015-2020)
Table 71. Global Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Type (2020-2025)
Table 72. Global Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Type (2020-2025)
Table 73. United States Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Type (2015-2020)
Table 74. United States Gastrointestinal Therapeutics and Diagnostics Revenue Share by Type (2015-2020)
Table 75. United States Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Type (2020-2025)
Table 76. United States Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Type (2020-2025)
Table 77. Global Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Application (2015-2020)
Table 78. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Application (2015-2020)
Table 79. Global Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Application (2020-2025)
Table 80. Global Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Application (2020-2025)
Table 81. United States Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Application (2015-2020)
Table 82. United States Gastrointestinal Therapeutics and Diagnostics Revenue Share by Application (2015-2020)
Table 83. United States Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Application (2020-2025)
Table 84. United States Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Gastrointestinal Therapeutics and Diagnostics Picture
Figure 2. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type in 2019
Figure 4. Diagnostics Picture
Figure 5. Therapeutics Picture
Figure 6. Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application in 2019
Figure 7. Gastroenteritis Picture
Figure 8. GI Bleeding Picture
Figure 9. Irritable Bowel Syndrome Picture
Figure 10. Peptic Ulcer Disease (PUD) Picture
Figure 11. Others Picture
Figure 12. Global Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2015-2025) (USD Million)
Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Regions (2015-2025)
Figure 14. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Regions in 2019
Figure 15. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Regions (2020-2025)
Figure 16. North America Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. Europe Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. South America Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 21. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Gastrointestinal Therapeutics and Diagnostics Revenue Market Share in 2019
Figure 23. Top 10 Players Gastrointestinal Therapeutics and Diagnostics Revenue Market Share in Global Market in 2019
Figure 24. Global Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) by Type (2015-2025)
Figure 25. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application (2015-2025)
Figure 26. North America Gastrointestinal Therapeutics and Diagnostics Market Size Share by Countries (2015-2025)
Figure 27. North America Gastrointestinal Therapeutics and Diagnostics Market Size Share by Countries in 2019
Figure 28. United States Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 29. Canada Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 30. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 31. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Share by Countries (2015-2025)
Figure 32. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Share by Countries in 2019
Figure 33. Germany Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 34. France Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 35. Russia Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 36. Italy Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 37. Spain Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 38. UK Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 39. Asia Gastrointestinal Therapeutics and Diagnostics Market Size Share by Countries (2015-2025)
Figure 40. Asia Gastrointestinal Therapeutics and Diagnostics Market Size Share by Countries in 2019
Figure 41. China Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 42. Japan Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 43. Korea Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 44. India Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 45. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 46. South America Gastrointestinal Therapeutics and Diagnostics Market Size Share by Countries (2015-2025)
Figure 47. South America Gastrointestinal Therapeutics and Diagnostics Market Size Share by Countries in 2019
Figure 48. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 49. Argentina Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 50. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Share by Countries (2015-2025)
Figure 51. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Share by Countries in 2019
Figure 52. Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 53. UAE Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 54. Egypt Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 55. South Africa Gastrointestinal Therapeutics and Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 56. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Type (2015-2020)
Figure 57. United States Gastrointestinal Therapeutics and Diagnostics Revenue Share by Type (2015-2020)
Figure 58. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Application (2015-2020)
Figure 59. United States Gastrointestinal Therapeutics and Diagnostics Revenue Share by Application (2015-2020)




Companies Mentioned
Abbott Laboratories
Johnson & Johnson
AstraZeneca
Eisai
Takeda Pharmaceutical Company
Salix Pharmaceuticals

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets